DDW: AI Outperforms Patients in Characterizing Stool Samples
TUESDAY, May 31, 2022 (HealthDay News) -- A novel smartphone application can accurately determine Bristol Stool Scale (BSS) and other visual stool characteristics, according to a study recently published in the American Journal of Gastroenterology and presented at the 2022 Digestive Disease Week, held from May 21 to 24 in San Diego.
Mark Pimentel, M.D., from Cedars-Sinai in Los Angeles, and colleagues evaluated the accuracy of a novel smartphone application that uses trained artificial intelligence to assess stool characteristics.
The researchers found that in the validation phase, there was good agreement between two experts and AI characterizations for BSS, stool consistency, edge fuzziness, fragmentation, and volume. Compared with self-reports from study participants with diarrhea-predominant irritable bowel syndrome, AI outperformed for categorizing daily average BSS scores as constipation, normal, or diarrhea. Agreement between AI and self-reported BSS scores in the implementation phase was moderate. For diarrhea severity scores, AI stool characterization was found to correlate better than participant reports.
"The artificial intelligence tool removes the subjective description that can be part of a patient's description of their bowel specimens," a coauthor said in a statement. "In addition to improving a physician's ability to assess their patients' digestive health, this app could be advantageous for clinical trials by reducing the variability of stool outcome measures."
One author is an employee and board member of Dieta Health.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Higher Fish Intake May Increase Melanoma Risk
FRIDAY, June 10, 2022 (HealthDay News) -- Higher total fish intake is associated...
Topical Antibiotics Shorten Duration of Conjunctival Symptoms
TUESDAY, Oct. 4, 2022 (HealthDay News) -- For children with acute infective...
FDA Approves Izervay for Geographic Atrophy Tied to Age-Related Macular Degeneration
WEDNESDAY, Aug. 9, 2023 (HealthDay News) -- The U.S. Food and Drug...
Adjuvant Therapy Recommendations for Breast Cancer Drop Between Ages 69 and 70
FRIDAY, Feb. 3, 2023 (HealthDay News) -- Between ages 69 and 70 years, there is...